(2E)-3-(4-bromophenyl)-1-(2,4-dimethoxyphenyl)prop-2-en-1-one, 95.0%, 10g

Canertinib, 98%, 50mg

(5-(Benzylcarbamoyl)-2-fluorophenyl)boronic acid, 95.0%, 1g

Tetraethylammonium iodide, 95.0%, 500g

(3-Acryloxypropyl)tris(trimethylsiloxy)silane inhibited with MEHQ tech-95, 95+%, 25g

METHYL 5-FORMYL-2-NITROBENZOATE, 95%, 10g

tert-Butyl 2-amino-7,8-dihydropyrido[3,2-d]pyrimidine-5(6H)-carboxylate, 97%, 250mg

tert-butyl 3-(cycloheptylamino)-2-methylpropanoate, 95.0%, 2g

N-(tert-Butoxycarbonyl)-L-leucinol>98.0%(GC)5g

Myricitrin, 91%, 5g

Tert-butyl (2R,3R)-2,3-dimethylpiperazine-1-carboxylate, 98%, 250mg

n',n'-Diphenyl-1h-pyrrole-2-carbohydrazide, 98%, 250mg

METHYL 3-BROMO-5-METHYLTHIOPHENE-2-CARBOXYLATE, 95.0%, 1g